01
ABOUT THE EVENT
II Global Virtual Symposium on Schistosomiasis
SCHISTOSOMA 2026
June 2, 2026
Format: Virtual (EDT)
Organized by: Impact Research Communications (IRC)
The 2026 Global Virtual Symposium on Schistosomiasis
convened leading parasitologists, immunologists, and
clinicians to advance knowledge on schistosome biology,
host-parasite interactions, diagnostics, vaccines, and
therapeutic strategies. Over a full day of sessions,
the symposium showcased breakthroughs in molecular
technologies, immune mechanisms, vaccine development,
and clinical interventions—underscoring the urgent
need for innovation in combating schistosomiasis worldwide.
02
SCIENTIFIC HIGHLIGHTS
Day Highlights
Session I: Molecular Technologies & Diagnostics
-
Dr. Hong You (Australia)
presented next-generation molecular tools
for enhanced schistosomiasis control.
-
Dr. Fabien Prodjinotho (Germany)
highlighted lipid metabolism as a vulnerability
in schistosomes.
-
Dr. Joachim Richter (Germany)
updated WHO's ultrasound protocol
("Basel protocol") for schistosomiasis.
-
Dr. Carlos Graeff-Teixeira (Brazil)
raised concerns about accuracy in diagnostic studies.
Session II: Host-Parasite Interactions & Immunity
-
Dr. Parisa Kalantari (USA)
demonstrated how NLRP3 and AIM2 inflammasomes
exacerbate Th17 responses to schistosome eggs.
-
Dr. Cecile Crosnier (UK)
used a human receptor platform to map
extracellular host-parasite protein interactions.
-
Dr. Jayhun Lee (USA)
explored host and parasite factors modulating
schistosome development and immune evasion.
-
Dr. Thiago De Almeida Pereira (USA)
examined fibrosis pathways and therapeutic
opportunities.
Session III: Vaccines & Clinical Advances
-
Dr. Jeroen Pollet (USA)
reported protective immunity from mRNA vaccines
encoding Sm-TSP-2 variants.
-
Dr. Darrick Carter (USA)
shared interim clinical trial results
for the SchistoShield vaccine.
-
Dr. Miriam Tendler (Brazil)
presented progress on the Sm14 FABP vaccine
(Schistovac) in Brazil and Africa.
-
Dr. Jennifer Friedman (USA)
discussed RCT results on praziquantel treatment
in pregnant women.
-
Dr. Susannah Colt (USA)
reported RCT findings on praziquantel dosing
in preschool-aged children.
The symposium concluded with remarks emphasizing
the convergence of molecular innovation, immunology,
and clinical research in advancing schistosomiasis
management.
03
INTERNATIONAL COLLABORATION
Global Participation
Countries represented included:
Australia, Germany, Brazil, UK, USA
,
and others—reflecting the international scope of
schistosomiasis research and collaboration.